DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today reported financial results for its fourth quarter and fiscal year ended March 31, 2013.

Alkermes plc (NASDAQ: ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss the company's financial results for its fiscal year ended March 31, 2013.

Freescale also supplies products to connectivity wireless, automotive, networking, energy, consumer, motor control, and the industrial markets.

Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Bank of America Merrill Lynch 2013 Smid Cap Conference on Wednesday, May 8, 2013, at 9:30 a.m.

NEW YORK -- Alkermes PLC said Thursday that it was profitable in its fiscal fourth quarter as it received bigger royalty payments and more revenue for drug manufacturing.

(Updated to include closing stock price.) It didn't look good for Alkermes PLC shares when the trading session started on Thursday, but it appears that once investors read the fine print in the company's earnings release, steep losses turned into gains ...

NASDAQ Active Stock Watch List: Apricus Biosciences, Inc. (NASDAQ:APRI), Express Scripts Holding Company (NASDAQ:ESRX), and Alkermes Plc (NASDAQ:ALKS) Added to Growing Stock Report's NASDAQ Active Stock Watch List. Forward · Print · Save ...

DUBLIN, May 16, 2013 (BUSINESS WIRE) -- Alkermes plc (NASDAQ:ALKS) will host a conference call at 8:00 a.m. EDT (1:00 p.m. BST) on Thursday, May 23, 2013, to discuss the company's financial results for its fiscal year ended March 31, 2013.

Alkermes plc's (ALKS - Analyst Report) fourth quarter of fiscal 2013 (ended Mar 31, 2013) adjusted earnings (including stock-based compensation expense) of 21 cents per share compared favorably to the year-ago loss of 13 cents per share.

Alkermes Plc ( NASDAQ : ALKS) shares traded in the range of $28.59 to $32.25 Thursday after releasing results for the fiscal year 2013.